Dr Reddy’s Laboratories has acquired the anti-vertigo brand Stugeron from Johnson & Johnson in 18 EMEA and APAC markets, including India and Vietnam. The move strengthens its CNS portfolio and supports its goal to reach 1.5 billion patients by 2030
Hyderabad: The Biden administration has announced revised international air travel rules for those flying to the United States, with the rules to come into effect from November 8. According to a communiqué from the White House, details of which are available on www.cdc.gov/ and https://travel.state.gov/content/travel.html as well, starting November 8, all foreign national air travellers […]
The American pharma J&J said in a statement that it had submitted its application on Tuesday, and that it is "imperative" to ensure all sections of the population, including children, are vaccinated against the coronavirus as quickly as possible to stop the virus.
India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines.
The Johnson & Johnson pause, which regulators say they hope to resolve within days, comes on the heels of production issues at the Baltimore plant that produces the J& J vaccine.
Dr. Saul Faust, who is helping lead the study, said the research will start first in Britain but aims to recruit a total of 30,000 people in six countries around the world.
The production area where it is intended that the vaccine candidates will be manufactured has the capacity to produce more than 300 million doses per annum, the company said.
The pause means the online enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.
